Facebook mentions regarding statins and side effects

Facebook mentions regarding statins and side effects Reactions 1664, p9 - 12 Aug 2017 Facebook mentions regarding statins and side effects Use of a commercial data-mining product identified 25 700 Facebook mentions regarding statins in a month, according to study results reported in Drug Safety, 4.3% of which also mentioned relevant side effects. The study involved Sysomos as an institutional data partner which resells data from the Facebook/Datasift consortium. Mentions of 71 prespecified keywords and keyphrases in any Facebook story or interaction were recorded between 9 January 2017 and 8 February 2017. Summary aggregate statistics were provided for US adults ≥35 years of age, rounded up to the nearest 100 mentions. The most common topic for the 25 700 mentions was atorvastatin. Shared links included those to health policy, health politics, medical, nutritional and general informational websites. Typical statin side effects were mentioned by 1200 users, referring to formal terms (n=55) or informal terms (n=700). The frequency of mentioning statin-related side effects was similar across all age brackets. The authors note that as the actual text of the Facebook posts are unavailable, it is unknown whether postings represented the user’s own use of statins, and that separation of causal or coincidental links is impossible. In addition, the search criteria used were not exhaustive, and their reliability was untested. However, "these findings suggest patients who take statins do not discuss this widely on Facebook". "The use of online social networks to listen for early evidence of drug side effects has theoretical potential," note the authors, "but the reality of data availability remains a serious challenge". They note that "partnering directly with Facebook could overcome this obstacle, although privacy constraints may stymie this promise". Huesch MD. Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook. Drug Safety : 26 Jul 2017 803263323 0114-9954/17/1664-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 12 Aug 2017 No. 1664 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Facebook mentions regarding statins and side effects

Reactions Weekly , Volume 1664 (1) – Aug 12, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/facebook-mentions-regarding-statins-and-side-effects-wGe50td2yr
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-34289-1
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial